Targeted Oncology3d
Atypical Chronic Myeloid Leukemia: A Rare Disease With Poor Prognosis
Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.
Novel treatment regimen yields promising response in advanced-phase chronic myeloid leukemia
According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...
News Medical on MSN4d
Innovative triplet therapy shows encouraging results in advanced chronic myeloid leukemia
According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...
Leukemia patient receives first-ever bone marrow transplant from deceased organ donor
The bioengineering company Ossium Health has created a new program that offers deep-frozen bone marrow from deceased organ ...
News Medical on MSN10d
$1.2 million NIH grant may help unravel the interplay between Down syndrome and myeloid leukemia
A four-year, $1.2 million grant from the National Cancer Institute of the National Institutes of Health may help researchers ...